Market research
005250.KO Green Cross Holdings Corporation
KO KRW Healthcare
Latest close
As of 27 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 427B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 3.1%
- Beta
- 0.56
Profile
Company facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- KR7005250006
- Market cap
- 427B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 3.1%
- Beta
- 0.56
About
About Green Cross Holdings Corporation
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille's syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.
Research context
Green Cross Holdings Corporation appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 005250.KO discussion.
5 years, 6 months ago
Green Cross Holdings Corporation is currently in a long term downtrend where the price is trading 6.3% below its 200 day moving average.
From a valuation standpoint, the stock is 89.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Green Cross Holdings Corporation's total revenue rose by 35.2% to $506B since the same quarter in the previous year.
Its net income has increased by 2978.6% to $123B since the same quarter in the previous year.
Finally, its free cash flow grew by 208.2% to $30B since the same quarter in the previous year.
Based on the above factors, Green Cross Holdings Corporation gets an overall score of 4/5.